Anuku Desmond, Carrier Marc, Le Gal Grégoire, Castellucci Lana, Wells Philip, Siegal Deborah, Wang Tzu-Fei, Duffett Lisa, Kimpton Miriam, Shaw Joseph, Morgan Tamara L, Cénat Jude-Mary, Delluc Aurélien, Xu Yan
Department of Medicine, Ottawa Hospital Research Institute, University of Ottawa, Ottawa, Ontario, Canada; Faculty of Public Affairs, Carleton University, Ottawa, Ontario, Canada.
Department of Medicine, Ottawa Hospital Research Institute, University of Ottawa, Ottawa, Ontario, Canada; School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada.
J Thromb Haemost. 2025 Jan;23(1):248-253. doi: 10.1016/j.jtha.2024.09.014. Epub 2024 Oct 21.
Limited language proficiency is an established barrier to research participation among racialized populations. While prior studies have highlighted the underrepresentation of racialized populations in venous thromboembolism (VTE) research, the impact of limited language proficiency as a reason for nonconsent among eligible patients is unknown.
To determine the impact of language barrier as the primary reason for VTE research non-participation.
We reviewed all prospective VTE studies conducted at a research-intensive academic thrombosis research program in Canada between 2014 and 2024. Studies with screening logs that systematically and consecutively captured eligibility assessment and reasons for nonconsent were included. Primary outcome was nonconsent of a screen-eligible patient due to limited language proficiency as the reported reason. We derived pooled estimates of nonconsent due to limited language proficiency as a proportion of consented participants and determined subgroup rates by phase of VTE management, associated medical conditions, and recruitment settings.
Screening logs of 28 studies with 22 057 screening events, 8317 screen-eligible patients, and 3320 consented participants were included. For every 100 consented participants, 3.2 (95% CI, 2.0-5.3) screen-eligible individuals were unable to provide consent due to limited language proficiency. Rates of nonconsent were highest in studies involving cancer (5.6 per 100 participants; 95% CI, 2.9-10.4) and in studies recruiting patients from ambulatory settings outside of the thrombosis clinic (10.8 per 100 participants; 95% CI, 4.8-22.6).
Language proficiency is a key barrier to VTE research participation. Urgent implementation of targeted interventions aimed at mitigating linguistic barriers is essential to ensure equitable opportunities for VTE research participation for racialized patients disproportionately affected by language proficiency.
语言能力有限是种族化人群参与研究的既定障碍。虽然先前的研究强调了种族化人群在静脉血栓栓塞症(VTE)研究中的代表性不足,但语言能力有限作为符合条件的患者不同意参与研究的原因所产生的影响尚不清楚。
确定语言障碍作为VTE研究不参与的主要原因所产生的影响。
我们回顾了2014年至2024年在加拿大一个研究密集型学术血栓形成研究项目中进行的所有前瞻性VTE研究。纳入了具有筛查日志的研究,这些日志系统且连续地记录了资格评估和不同意参与的原因。主要结局是由于语言能力有限作为报告原因而导致符合筛查条件的患者不同意参与。我们得出了因语言能力有限而不同意参与的合并估计值,以同意参与的参与者比例表示,并按VTE管理阶段、相关医疗状况和招募地点确定亚组率。
纳入了28项研究的筛查日志,这些研究共有22057次筛查事件、8317名符合筛查条件的患者和3320名同意参与的参与者。每100名同意参与的参与者中,有3.2名(95%CI,2.0 - 5.3)符合筛查条件的个体因语言能力有限而无法提供同意书。不同意参与的比例在涉及癌症的研究中最高(每100名参与者中有5.6名;95%CI,2.9 - 10.4),在从血栓形成诊所以外的门诊环境招募患者的研究中也最高(每100名参与者中有10.8名;95%CI,4.8 - 22.6)。
语言能力是参与VTE研究的关键障碍。迫切需要实施有针对性的干预措施以减轻语言障碍,这对于确保受语言能力影响尤为严重的种族化患者有平等的机会参与VTE研究至关重要。